Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: A feasibility study

Gastrointestinal Endoscopy

Volumn 74, Issue 1, 2011, Pages 87-95

  Zubarik, Richard ^a   Gordon, Stuart R ^b   Lidofsky, Steven D ^a   Anderson, Scott R ^a   Pipas, J Marc ^b   Badger, Gary ^a   Ganguly, Eric ^a   Vecchio, James ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; FEASIBILITY STUDY; FEMALE; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; REIMBURSEMENT;

ADENOCARCINOMA; CA-19-9 ANTIGEN; EARLY DETECTION OF CANCER; ENDOSONOGRAPHY; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 79959709032     PISSN: 00165107     EISSN: 10976779     Source Type: Journal    
DOI: 10.1016/j.gie.2011.03.1235     Document Type: Article

References (29)

1. U.S. Cancer Statistics Working Group United States Cancer Statistics: 2002 Incidence and Mortality 2005 U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute Atlanta
2. S. Sener, A. Fremgen, and H.R. Menck Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1999 1 7 (Pubitemid 29307735)
3. C.J. Yeo, J.L. Cameron, and T.A. Sohn Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s; pathology, complications and outcomes Ann Surg 226 1997 248 260
4. K. Satake, T. Takeuchi, and T. Homma CA 19-9 as a screening and diagnostic tool in symptomatic patients: the Japanese experience Pancreas 9 1994 703 706 (Pubitemid 24317820)
5. J. Kim, K.T. Lee, and J.K. Lee Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population J Gastroenterol Hepatol 19 2004 182 186 (Pubitemid 38253358)
6. M.I. Canto, M. Goggins, and R.H. Hruban Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study Clin Gastroenterol Hepatol 4 2006 766 781 (Pubitemid 43825802)
7. M.B. Kimmey, M.P. Bronner, and D.R. Byrd Screening and surveillance for hereditary pancreatic cancer Gastrointest Endosc 56 2002 S82 S86
8. E.C. Verna, C. Hwang, and P.D. Stevens Pancreatic cancer screening in a prospective cohort of high-risk patients: a comprehensive strategy of imaging and genetics Clin Cancer Res 16 2010 5028 5037
9. P. Langer, P.H. Kahn, and V. Fendrich Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer Gut 58 2009 1410 1418
10. A.C. Tersmette, G.M. Peterson, and G.J.A. Offerhaus Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer Clin Cancer Res 7 2001 738 744 (Pubitemid 32708001)
11. R.R. McWilliams, K.G. Rabe, and C. Olswold Risk of Malignancy in first-degree relatives of patients with pancreatic carcinoma Cancer 104 2005 388 394 (Pubitemid 40993268)
12. K. Helminki, and X. Li Familial and second primary pancreatic cancers Int J Cancer 103 2003 525 530
13. S.S. Coughlin, E.E. Calle, and A.V. Patel Predictors of pancreatic cancer mortality among a large cohort of United States adults Cancer Causes Control 11 2000 915 923 (Pubitemid 32005303)
14. D.T. Silverman, M. Schiffman, and J. Everhart Diabetes Mellitus, other medical conditions, and familial history of pancreatic cancer as risk factors for pancreatic cancer Br J Cancer 80 1999 1830 1837 (Pubitemid 29389642)
15. M. Schenk, A.G. Schwartz, and E. O'Neal Familial risk of pancreatic cancer J Natl Cancer Inst 93 2001 640 644 (Pubitemid 32409632)
16. M.D. Chiaro, A. Zerbi, and M. Falconi Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma Pancreatology 7 2007 459 469 (Pubitemid 47587625)
17. E. Fernandez, C. La Vecchia, and B. D'Avanzo Family History and the risk of liver, gallbladder, and pancreatic cancer Cancer Epidemiol Biomarkers Prev 3 1994 209 212 (Pubitemid 24172532)
18. T. Okusaka, T. Yamada, and M. Maekawa Serum tumor markers for pancreatic cancer: the dawn of new era? JOP 7 2006 332 336 (Pubitemid 44083104)
19. W.M. Steinberg, R. Gelfand, and K.K. Anderson Comparison of the sensitivity and specificity of the CA 19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas Gastroenterology 90 1986 343 349 (Pubitemid 16136674)
20. AJCC Cancer Staging Manual 6th ed. 2002 Springer Chicago, Ill
21. K.Y. Bilimoria, D.J. Bentrem, and C.Y. Ko Validation of the 6th edition AJCC Pancreatic Cancer Staging System Cancer 110 2007 738 744
22. National Cancer Institute SEER Cancer Statistics Review 1975-2006 Lifetime Risk (Percent) of Being Diagnosed with Cancer by Site and Race/Ethnicity: Males, 17 SEER Areas, 2004-2006 (Table 1-15) and Females, 17 SEER Areas, 2004-2006 (Table 1-16) 2009 http://seer.cancer.gov/csr/1975-2006/ browse-csr.php?section=1&page=sect-01-table.16.html Accessed June 22, 2009
23. L.W. Traverso, E.A. Peralt, and J.A. Ryan Jr Intraductal neoplasms of the pancreas Am J Surg 175 1998 426 432 (Pubitemid 28213460)
24. S. Egawa, K. Takeda, and S. Fukuyama Clinicopathological aspects of small pancreatic cancer Pancreas 28 2004 235 240 (Pubitemid 38437315)
25. M.A. Tempero, E. Uchida, and H. Takasaki Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer Cancer Res 47 1987 5501 5503 (Pubitemid 17152971)
26. J. DeWitt, B. Devereaux, and M. Chriswell Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer Ann Intern Med 141 2004 754 763
27. K. Volmar, R. Vollmer, and P.S. Jowell Pancreatic FNA in 1000 cases: a comparison of imaging modalities Gastrointest Endosc 61 2005 854 861 (Pubitemid 40779416)
28. D.G. Adler, B.C. Jacobson, and R.E. Davila ASGE guideline: complications of EUS Gastrointest Endosc 61 2005 8 12 (Pubitemid 40169804)
29. M. Canto, R.D. Shulick, and I.R. Kamel Screening for familial pancreatic neoplasia:a prospective, multicenter blinded study of EUS, CT, and secretin-MRCP (The NCI-Spore Lustgarten Foundation Cancer of the Pancreas CAPS 3 Study [abstract].) Gastrointest Endosc 71 2010 AB119